Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine

Investigational New Drugs

Volumn 26, Issue 4, 2008, Pages 319-330

  Aggarwal, Ashish ^a   Kruczynski, Anna ^b   Frankfurter, Anthony ^c   Correia, John J ^a   Lobert, Sharon ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Apoptosis; G2 M arrest; Tubulin; Tubulin isotypes; Vinca alkaloid resistance; Vinca alkaloids; Vinflunine

Indexed keywords

BETA TUBULIN; CYTOCHROME C; LIPOCORTIN 5; MULTIDRUG RESISTANCE PROTEIN 1; NAVELBINE; PROPIDIUM IODIDE; VINBLASTINE; VINFLUNINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; CROSS RESISTANCE; DOSE RESPONSE; DRUG MECHANISM; DRUG SENSITIVITY; FLOW CYTOMETRY; MEMBRANE DEPOLARIZATION; MOUSE; MURINE LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; CYTOCHROMES C; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; G2 PHASE; INHIBITORY CONCENTRATION 50; LEUKEMIA P388; MICE; MITOCHONDRIAL MEMBRANES; VINBLASTINE;

EID: 45849148932     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10637-007-9102-3     Document Type: Article

References (35)

1. Bhattacharya R, Cabral F (2004) A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. Mol Biol Cell 15:3123-3131
2. Blade K, Menick DR, Cabral F (1999) Overexpression of class I, II or IVb beta-tubulin isotypes in CHO cells is insufficient to confer resistance to Paclitaxel. J Cell Sci 112(13):2213-2221
3. Borst P, Elferink RO (2002) Mammalian ABC transporters in health and disease. Annu Rev Biochem 71:537-592
4. Bosch I, Croop J (1996) P-Glycoprotein multidrug resistance and cancer. Biochim Biophys Acta 1288:F37-F54
5. Caceres A, Binder LI, Payne MR, Bender P, Rebhun L, Steward O (1984) Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal hybridoma antibodies. J Neurosci 4:394-410
6. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′6,6′- tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197:40-45
7. Dumontet C, Jaffrezou JP, Tsuchiya E, Duran GE, Chen G, Derry WB, Wilson L, Jordan MA, Sikic BI (2004) Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization. Bull Cancer 91:E81-E112
8. Etievant C, Barret JM, Kruczynski A, Perrin D, Hill BT (1998) Vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine), a novel vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. Invest New Drugs 16:3-17
9. Etievant C, Kruczynski A, Barret JM, Tait AS, Kavallaris M, Hill BT (2001) Markedly diminished drug resistance-inducing properties of vinflunine (20′,20′-difluoro-3′,4′-dihydrovinorelbine) relative to vinorelbine, identified in murine and human tumour cells in vivo and in vitro. Cancer Chemother Pharmacol 48:62-70
10. Fabbri F, Carloni S, Brigliadori G, Zoli W, Lapalombella R, Marini M (2006) Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: a cytometric study. BMC Cell Biol 7:6
11. Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M (2005) Structural basis for the regulation of tubulin by vinblastine. Nature 435:519-522
12. Hari M, Yang H, Zeng C, Canizales M, Cabral F (2003) Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel. Cell Motil Cytoskelet 56:45-56
13. Hill BT (2001) Vinflunine, a second generation novel vinca alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers. Curr Pharm Des 7:1199-1212
14. Hiser L, Aggarwal A, Young R, Frankfurter A, Spano A, Correia JJ, Lobert S (2006) Comparison of beta-tubulin MRNA and protein levels in 12 human cancer cell lines. Cell Motil Cytoskelet 63:41-52
15. Jacquesy J, Fahy J (2000) Cancer: superacid generation of new antitumor agents. In: Torrence PF (ed) Biomedical chemistry: applying chemical principles to the understanding and treatment of disease. Wiley, New York, pp 227-245
16. Kruczynski A, Barret JM, Etievant C, Colpaert F, Fahy J, Hill BT (1998) Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated vinca alkaloid. Biochem Pharmacol 55:635-648
17. Kruczynski A, Hill BT (2001) Vinflunine, the latest vinca alkaloid in clinical development. A review of its preclinical anticancer properties. Crit Rev Oncol Hematol 40:159-173
18. Kruczynski A, Etievant C, Perrin D, Chansard N, Duflos A, Hill BT (2002) Characterization of cell death induced by vinflunine, the most recent vinca alkaloid in clinical development. Br J Cancer 86:143-150
19. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A (1990) The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskelet 17:118-132
20. Lobert S, Correia JJ (2000) Energetics of vinca alkaloid interactions with tubulin. Methods Enzymol 323:77-103
21. Lobert S, Frankfurter A, Correia JJ (1995) Binding of vinblastine to phosphocellulose-purified and alpha beta-class III tubulin: the role of nucleotides and beta-tubulin isotypes. Biochemistry 34:8050-8060
22. Lobert S, Frankfurter A, Correia JJ (1998) Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity. Cell Motil Cytoskelet 39:107-121
23. Lobert S, Ingram JW, Hill BT, Correia JJ (1998) A Comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity. Mol Pharmacol 53:908-915
24. Lobert S, Fahy J, Hill BT, Duflos A, Etievant C, Correia JJ (2000) Vinca alkaloid-induced tubulin spiral formation correlates with cytotoxicity in the leukemic L1210 cell line. Biochemistry 39:12053-12062
25. Masuda A, Maeno K, Nakagawa T, Saito H, Takahashi T (2003) Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers. Am J Pathol 163:1109-1116
26. Minderman H, Vanhoefer U, Toth K, Yin MB, Minderman MD, Wrzosek C, Slovak ML, Rustum YM (1996) DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Cytometry 25:14-20
27. Minotti AM, Barlow SB, Cabral F (1991) Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J Biol Chem 266:3987-3994
28. Ngan VK, Bellman K, Hill BT, Wilson L, Jordan MA (2001) Mechanism of mitotic block and inhibition of cell proliferation by the semisynthetic vinca alkaloids vinorelbine and its newer derivative vinflunine. Mol Pharmacol 60:225-232
29. Noble RL (1990) The discovery of the vinca alkaloids-chemotherapeutic agents against cancer. Biochem Cell Biol 68:1344-1351
30. Pourroy B, Carre M, Honore S, Bourgarel-Rey V, Kruczynski A, Briand C, Braguer D (2004) Low concentrations of vinflunine induce apoptosis in human SK-N-SH neuroblastoma cells through a postmitotic G1 arrest and a mitochondrial pathway. Mol Pharmacol 66:580-591
31. Roach MC, Boucher VL, Walss C, Ravdin PM, Luduena RF (1998) Preparation of a monoclonal antibody specific for the class I isotype of beta-tubulin: the beta isotypes of tubulin differ in their cellular distributions within human tissues. Cell Motil Cytoskelet 39:273-285
32. Scarlett JL, Sheard PW, Hughes G, Ledgerwood EC, Ku HH, Murphy MP (2000) Changes in mitochondrial membrane potential during staurosporine-induced apoptosis in Jurkat cells. FEBS Lett 475:267-272
33. Sullivan KF, Cleveland DW (1986) Identification of conserved isotype-defining variable region sequences for four vertebrate beta tubulin polypeptide classes. Proc Natl Acad Sci USA 83:4327-4331
34. Taylor SS, McKeon F (1997) Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727-735
35. Wang Y, Cabral F (2005) Paclitaxel resistance in cells with reduced beta-tubulin. Biochim Biophys Acta 1744:245-255